Aventior specializes in providing AI and ML-backed technologies and services to help you implement Pharma 4.0TM smoothly in your organization.

The certification was awarded for the Air France and KLM airline processes and its Charles de Gaulle and Schiphol hub operations.

The market for teleradiology services is expected to grow at CAGR of 16.83%, from 2021-2030.

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

Drug discovery is a sophisticated process involving the use of cutting-edge technologies and advanced scientific methods. It is a highly resource-intensive and expensive process. Amongst the different types of available drugs, the discovery and developmen...

The biopharmaceuticals market, characterized by a robust and promising pipeline, currently represents one of the fastest growing segments of the pharmaceutical industry. Over the years, there has been incremental evolution of concepts and methods, which h...

? More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are 25+ technology platforms available for use in therapy development efforts ? The pipeline features a vari...

STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies

Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demo...

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, clos...

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals h...

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise